Needham's Downward Revision of Nurix Therapeutics Stock Target Price
Friday, 12 July 2024, 08:47
Needham's Analysis of Nurix Therapeutics
Needham Investment Bank recently revised its price target for Nurix Therapeutics shares, citing financial adjustments.
Key Points:
- Downward Revision: Needham has decreased the target price for Nurix shares.
- Financial Adjustments: The revision is a response to recent financial changes within the company.
- Investor Consideration: This adjustment raises concerns about Nurix's financial outlook.
Investors should monitor Nurix Therapeutics closely following this price target revision.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.